An independent, not-for-profit projectFree knowledge. Better questions.
peptide.cyWhy we exist ↗
EVIDENCE GUIDE

Research peptide or approved medicine?

The molecule’s name does not establish the product’s medical status.

What it is

A research chemical, an active pharmaceutical ingredient and a finished prescription medicine are different products. A COA cannot substitute for clinical evaluation and regulated manufacturing.

What the evidence tells us

An approved medicine has a defined formulation, intended use and product information. A research supplier can sell a molecule with the same name without establishing equivalence.

What remains uncertain

For Cyprus and the EU, consult EMA product information and the relevant national authority. US FDA statements describe the US context. A directory listing is not confirmation of local legality, import eligibility or medical suitability.

Read the finding, not just the headline.

Check the population, product, route, comparator and outcome. A laboratory mechanism is not a proven health benefit, and a supplier’s certificate is not a clinical study.

Follow the evidence

Sources accessed 10 September 2026. Vendor claims and vendor-hosted reports are identified as such.

  1. EMA: Wegovy assessment and product information ↗
  2. FDA: concerns with unapproved GLP-1 drugs ↗
Suggest a correction or missing study →

Keep your curiosity going.

Quality guide⟐Start here

99% pure. But pure of what? ↗

The number on the label is only one part of the evidence.

Read the evidence →
Quality guide⌬Practical checklist

How to read a peptide COA ↗

Follow the sample, the method and the evidence back to their source.

Read the evidence →
Quality guide∿Two different questions

Endotoxins ≠ sterility ↗

A product can pass one test and fail the other.

Read the evidence →

Put the evidence side by side.